Pediatric guidelines for dyslipidemia

Journal of Clinical Lipidology
Stephen R Daniels

Abstract

Clinical guidelines are developed to assist clinicians in complex clinical decision making. Modern guideline development includes a systematic review and grading of relevant literature and then using the evidence review to construct recommendations for clinical care which are also graded regarding the level of evidence supporting them. Pediatric guidelines for dyslipidemia were first published in 1992. There was then a gap during which no formal guidelines were developed. In 2011, the National Heart, Lung, and Blood Institute Integrated Guidelines for Cardiovascular Disease Risk Reduction in Children were published. This included an evidence review and clinical recommendations regarding dyslipidemia. This review process began in 2006. The evidence review ended in 2008, and they were published in 2011 because of an extensive and prolonged review process. These guidelines recommend universal screening for dyslipidemia at age 9 to 11 y with a focus on identifying young individuals with genetic dyslipidemia such as familial hypercholesterolemia. The guidelines also include lifestyle recommendations and recommendations for pharmacologic treatment for children with markedly elevated low-density lipoprotein cholesterol. The guideline ...Continue Reading

References

Dec 19, 1990·JAMA : the Journal of the American Medical Association·T B NewmanS B Hulley
Apr 1, 1993·American Journal of Diseases of Children·M W Gillman
Jul 4, 2008·Pediatrics·Stephen R DanielsUNKNOWN Committee on Nutrition
Jan 20, 2010·Pediatrics·UNKNOWN US Preventive Services Task Force, Mary Barton
Nov 16, 2011·Pediatrics·UNKNOWN Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, UNKNOWN National Heart, Lung, and Blood Institute
Dec 17, 2011·JAMA : the Journal of the American Medical Association·Bruce M Psaty, Frederick P Rivara
Jan 19, 2012·JAMA : the Journal of the American Medical Association·Matthew W Gillman, Stephen R Daniels
Apr 12, 2012·Pediatrics·Samuel S GiddingUNKNOWN Expert Panel on Cardiovascular Health and Risk Reduction in Youth
Apr 3, 2013·Pediatrics·Thomas B NewmanStephen B Hulley

❮ Previous
Next ❯

Citations

Dec 23, 2016·Clinical Pediatrics·Carole StipelmanNicole L Mihalopoulos
Jan 15, 2019·Journal of Pediatric Gastroenterology and Nutrition·Arianna Amália DégiAntal Dezsőfi
Jul 6, 2019·The Korean Journal of Internal Medicine·Eun-Jung RheeIn-Kyung Jeong
Aug 22, 2020·Journal of Lipid and Atherosclerosis·Eun-Jung RheeUNKNOWN Committee of Clinical Practice Guideline of Korean Society of Lipid and Atherosclerosis
Dec 3, 2020·Clinical and Experimental Pediatrics·Jung Sub LimUNKNOWN Committee of Dyslipidemia of Korean Children and Adolescents on behalf of Korean Society of Pediatric Endocrinology (KSPE)
Jan 7, 2021·Annals of Pediatric Endocrinology & Metabolism·Jung Sub LimUNKNOWN Committee of Dyslipidemia of Korean Children and Adolescents on behalf of Korean Society of Pediatric Endocrinology (KSPE)

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.